Information Provided By:
Fly News Breaks for November 19, 2018
NVO
Nov 19, 2018 | 04:58 EDT
JPMorgan analyst Richard Vosser upgraded Novo Nordisk to Overweight and raised his price target for the shares to 340 kroner from 290 kroner. The analyst sees the company's growth strengthening through 2019.